Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Killer cell lectin-like receptor G2 (KLRG2) is a membrane protein predicted to function in carbohydrate binding, with likely roles as a cell surface receptor in immune cells. It belongs to the C-type lectin-like receptor family and is encoded by the KLRG2 gene (also known as CLEC15B), located on human chromosome 7. Its detailed ligand specificity, signaling mechanisms, and clinical relevance are not comprehensively characterized in current public sources, though its structure and gene annotation are well defined[1][3][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Killer cell lectin-like receptor G2 (KLRG2).